Datavault AI Inc.
For the period ended Mar 31, 2025. Filed May 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 14, 2025
DVLT$0.06+3.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands)
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, | ||||||
| · 2025 · 2024 | ||||||
| Cash flows from operating activities: · · | ||||||
| Net income (loss) | | $(9,563) | | $2,707 | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | | | | |||
| Stock-based compensation | | | 648 | | | 380 |
| Depreciation and amortization | | | 2,321 | | | 20 |
| Amortization of debt discounts | | | 120 | | | 1,260 |
| Change in fair value of warrant liability | | | (17) | | | (8,129) |
| Changes in operating assets and liabilities: | | | | | ||
| Accounts receivable | | 69 | | 4 | ||
| Inventories | | 276 | | 158 | ||
| Prepaid expenses and other current assets | | 359 | | 35 | ||
| Other assets | | | 54 | | | 34 |
| Accounts payable | | (291) | | 223 | ||
| Accrued liabilities | | 30 | | (229) | ||
| Other liabilities | | (30) | | (3) | ||
| Net cash used in operating activities | | (6,024) | | (3,540) | ||
| | | | | | | |
| Cash flows from investing activities: | | | ||||
| Deposits for business combination | | | (1,000) | | | — |
| Purchases of property and equipment | | (52) | | (6) | ||
| Net cash used in investing activities | | (1,052) | | (6) | ||
| | | | | | | |
| Cash flows from financing activities: | | | ||||
| Proceeds from issuance of common stock, net of issuance costs | | | 4,945 | | | — |
| Proceeds from issuance of short-term loan, net of issuance costs | | | — | | | 600 |
| Proceeds from issuance of common stock and prefunded warrants, net of issuance costs | | | — | | | 11,517 |
| Proceeds from exercise of warrants | | | — | | | 714 |
| Repurchase of common stock warrants | | | (622) | | | — |
| Repurchase of Series B preferred stock and warrants | | | — | | | (6,266) |
| Repayment of convertible note principal and accrued interest | | | (406) | | | — |
| Repayment of short-term loan | | | — | | | (667) |
| Net cash provided by financing activities | | 3,917 | | 5,898 | ||
| | | | | | | |
| Net decrease in cash and cash equivalents | | (3,159) | | 2,352 | ||
| Cash and cash equivalents as of beginning of period | | 3,330 | | 411 | ||
| Cash and cash equivalents as of end of period | | $171 | | $2,763 | ||
| | | | | | | |
| Supplemental disclosure of cash flow information: | | | | | | |
| Cash paid for interest | | $62 | | $272 | ||
| | | | | | | |
| Noncash Investing and Financing Activities: | | | ||||
| Capitalized acquistion costs | | $117 | | $— | ||
| Issuance of warrant liability in connection with financing | | $— | | $8,701 | ||
| Deemed dividend on conversion of Series B preferred stock and repurchase of Series B preferred stock | | $— | | $(5,842) | ||
| Unpaid financings issuance costs | | $86 | | $714 | ||
| Unpaid deferred offering costs | | $117 | | $— | ||
| Reclass liability warrant to equity | | $15 | | $— | ||
| Cashless exercise of warrants | | $— | | $587 | ||
| warrant exercise in connection with loan settlement | | $— | | $(333) | ||
| Issuance of common stock in connection with Series B preferred stock | | $— | | $325 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.